PLEK2 mediates metastasis and vascular invasion via the ubiquitin‐dependent degradation of SHIP2 in non‐small cell lung cancer-Reference-Cited by-同舟云学术

PLEK2 mediates metastasis and vascular invasion via the ubiquitin‐dependent degradation of SHIP2 in non‐small cell lung cancer

Published:2019-11-06 Issue:9 Volume:146 Page:2563-2575
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Wu Dong‐Ming¹,Deng Shi‐Hua¹,Zhou Jin²,Han Rong¹,Liu Teng¹,Zhang Ting¹,Li Jing¹,Chen Jian‐Ping³,Xu Ying¹^ORCID

Affiliation:

1. Clinical Laboratory The First Affiliated Hospital of Chengdu Medical College Chengdu Sichuan China

2. School of Medicine, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center University of Electronic Science and Technology of China Chengdu Sichuan China

3. West China School of Basic Medical Sciences and Forensic Medicine Sichuan University Chengdu Sichuan China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.32675

Reference30 articles.

1. Global cancer statistics, 2012

2. Incidence of brain metastasis at initial presentation of lung cancer

3. EMT and MET in Metastasis: Where Are the Cancer Stem Cells?

4. STAT3 activation in endothelial cells is important for tumor metastasis via increased cell adhesion molecule expression

5. Tumor angiogenesis: molecular pathways and therapeutic targets

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PLEK2 promotes migration and invasion in pancreatic ductal adenocarcinoma by MMP1 through IL-17 pathway;Molecular and Cellular Biochemistry;2024-08-09

2. Pleckstrin-2 Mediates the Activation of AKT in Prostate Cancer and Is Repressed by Androgen Receptor;The American Journal of Pathology;2024-07

3. Tankyrase 2 promotes lung cancer cell malignancy;World Journal of Clinical Oncology;2024-06-24

4. PLEK2 activates the PI3K/AKT signaling pathway to drive lung adenocarcinoma progression by upregulating SPC25;Cell Biology International;2024-06-18

5. E3 ubiquitin ligases in lung cancer: Emerging insights and therapeutic opportunities;Life Sciences;2024-01